- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 05.02. | The Illusion of Diversion Data: Why Confirmed Diversion Counts Misrepresent True Risk | ||
| 05.02. | Choosing the Right Methods for the Right AI to Accelerate Prior Authorizations | ||
| 05.02. | DexCom's CEO Believes Diabetics On GLP-1s Should Also Wear CGMs | ||
| 04.02. | Baldness Biotech Veradermics Prices $256M IPO for Pivotal Tests of Pill for Hair Loss | ||
| 04.02. | Digital Health's Latest Unicorn: Why Investors Are Backing Midi's Model for Women's Health | ||
| 04.02. | Cancer Detection Startup Secures $4M to Expand Access in Underserved Communities | ||
| 04.02. | The $25.7B Healthcare Problem AI Is Finally Solving | ||
| 04.02. | PGx Testing: Specialists Benefit From, and Build Upon Oncology's Success | ||
| 04.02. | Alaffia Health Snags $55M for AI Engine Tackling Healthcare's Waste Problem | ||
| 04.02. | Included Health Launches Alternative Plan Design for Employers | ||
| 03.02. | Data for Pfizer's Monthly Injectable GLP-1 Drug Pave Way for Broad Phase 3 Plan in Obesity | ||
| 03.02. | Stop Treating Patches Like They're Riskier Than Ransomware | ||
| 03.02. | How AI and Predictive Analytics Will Shape EMS, Fire, and Healthcare in 2026 | ||
| 03.02. | The 4 Biotech Companies on Track to IPO this Week Despite the Government Shutdown | ||
| 03.02. | WellTheory Introduces Autoimmune Postpartum Program | ||
| 02.02. | How DiME's New Pediatric Rare Disease Project Could Make Clinical Trials Faster | ||
| 02.02. | MedCity FemFwd: Why Women's Health Is a Scalable Sector | ||
| 02.02. | Optimizing Care Pathways: The Next Frontier in Rehab Performance | ||
| 02.02. | Can AI Bridge the Gaps in Women's Healthcare? A Responsible Path Forward | ||
| 01.02. | Premise-Crossover Merger: Inside the $2B Push for a New Employer Health Model | ||
| 01.02. | Is It Time to Change the Independent Dispute Resolution Process of the No Surprises Act? | ||
| 01.02. | Medication Affordability Depends on Total Price Transparency | ||
| 01.02. | 2026 Is the Year of the Doctor-Patient Relationship | ||
| 01.02. | Clinical Trial Holds Cast Doubt on Approval Chances of Regenxbio Gene Therapy for Rare Disease | ||
| 30.01. | AstraZeneca Beefs Up in Metabolic Disease, Paying $1.2B to Partner on CSPC Obesity & Diabetes Meds |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.